title: [Post-menopausal metrorrhagia. Use of danazol in endometrial hyperplasia].
abstract: The Authors, after a careful examination of the literature on endometrial hyperplasias, review the results of a preliminary study on 15 patients affected with postmenopausal metrorrhagia, cured by Danazol (200 mg/die) through 90 consecutive days. Also recognizing the best tolerance to the drug and the low incidence of the side effects, they think the results obtained by Danazol need further confirmation by more protracted controls.
authors.forename: A
authors.initials: A
authors.lastname: Baldoni
authors.forename: C
authors.initials: C
authors.lastname: Donati Sarti
authors.forename: G
authors.initials: G
authors.lastname: Affronti
authors.forename: L
authors.initials: L
authors.lastname: Liotta
authors.forename: V
authors.initials: V
authors.lastname: Martinoli
authors.forename: A G
authors.initials: AG
authors.lastname: Cosco
authors.forename: L
authors.initials: L
authors.lastname: Cardinali
authors.forename: G
authors.initials: G
authors.lastname: Pomili
authors.forename: E
authors.initials: E
authors.lastname: Giannone
mesh_terms: D003613:Danazol / Q000009:adverse effects / Q000627:therapeutic use*; D004714:Endometrial Hyperplasia / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008593:Menopause; D008796:Metrorrhagia / Q000209:etiology*; D011245:Pregnadienes / Q000627:therapeutic use*
chemical_list: D011245:Pregnadienes; D003613:Danazol
vernacular_title: Metrorragia post-menopausale. L'uso del danazolo nella iperplasia endometriale.